BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260417
DTEND;VALUE=DATE:20260423
DTSTAMP:20260421T090002
CREATED:20251125T143125Z
LAST-MODIFIED:20251125T143125Z
UID:9583-1776384000-1776902399@thebiocalendar.com
SUMMARY:AACR Annual Meeting 2026
DESCRIPTION:The AACR Annual Meeting is the focal point of the cancer research community\, where scientists\, clinicians\, other health care professionals\, survivors\, patients\, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology\, translational\, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
URL:https://thebiocalendar.com/event/aacr-annual-meeting-2026/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Annual Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260420
DTEND;VALUE=DATE:20260422
DTSTAMP:20260421T090002
CREATED:20260316T090716Z
LAST-MODIFIED:20260316T090716Z
UID:10021-1776643200-1776815999@thebiocalendar.com
SUMMARY:ICEBB 2026: 20. International Conference on Emerging Biosensors and Biotechnology
DESCRIPTION:The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality\, it provides an exceptional value for students\, academics and industry researchers. \nInternational Conference on Emerging Biosensors and Biotechnology aims to bring together leading academic scientists\, researchers and research scholars to exchange and share their experiences and research results on all aspects of Emerging Biosensors and Biotechnology. It also provides a premier interdisciplinary platform for researchers\, practitioners and educators to present and discuss the most recent innovations\, trends\, and concerns as well as practical challenges encountered and solutions adopted in the fields of Emerging Biosensors and Biotechnology.
URL:https://thebiocalendar.com/event/icebb-2026-20-international-conference-on-emerging-biosensors-and-biotechnology/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260421
DTEND;VALUE=DATE:20260422
DTSTAMP:20260421T090002
CREATED:20251211T120046Z
LAST-MODIFIED:20251211T120127Z
UID:9643-1776729600-1776815999@thebiocalendar.com
SUMMARY:BioLabs Investor Day Philadelphia
DESCRIPTION:More than ever\, great life science startups need extensive investor connections to be successful. That’s why BioLabs joins forces with key local ecosystem partners — drawing on our international network of investor relationships — to bring the money and the talent together. \nPhiladelphia’s third annual Investor Day event will bring together life science investors from across the country with startups from Philly’s groundbreaking ecosystem for a day of pre-selected lightning pitches\, poster sessions a lively panel of expert and invite-only networking.
URL:https://thebiocalendar.com/event/biolabs-investor-day-philadelphia/
LOCATION:Philadelphia\, Philadelphia\, PA\, United States
CATEGORIES:Investor
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260421
DTEND;VALUE=DATE:20260423
DTSTAMP:20260421T090002
CREATED:20260324T074121Z
LAST-MODIFIED:20260324T074121Z
UID:10063-1776729600-1776902399@thebiocalendar.com
SUMMARY:Life Science Innovation Northwest 2026
DESCRIPTION:Life Science Innovation Northwest (LSINW) is the Pacific Northwest’s premier life science event where the entire ecosystem comes together to spark breakthroughs\, shape the future\, and accelerate what comes next. This one-and-a-half-day conference brings the region’s innovators into one room to showcase today’s most compelling discoveries and tomorrow’s biggest opportunities. \nLSINW is the can’t-miss gathering for the PNW life science community. Nowhere else will you find CEOs\, investors\, research institutions\, global health leaders\, entrepreneurs\, and public and private life science organizations connecting at this scale. With high-impact programming\, elevated networking\, and dedicated time to meet strategic partners\, collaborators\, and investors\, LSINW 2026 is designed to help attendees build meaningful relationships that move ideas and companies forward.
URL:https://thebiocalendar.com/event/life-science-innovation-northwest-2026/
LOCATION:Seattle Convention Center\, 705 Pike St.\, Seattle\, WA\, 98101\, United States
CATEGORIES:Forum,Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260421T110000
DTEND;TZID=America/Los_Angeles:20260421T120000
DTSTAMP:20260421T090002
CREATED:20260325T132859Z
LAST-MODIFIED:20260325T132859Z
UID:10065-1776769200-1776772800@thebiocalendar.com
SUMMARY:Unlocking the next wave of cancer vaccines: Advancing mRNA-LNP delivery and small-scale manufacturing
DESCRIPTION:Personalized cancer vaccines (PCVs) are reshaping immuno-oncology. However\, translating these therapies into the clinic remains challenging. The progress is often slowed by critical bottlenecks – from suboptimal delivery\, limited access to novel lipid nanoparticle (LNP) formulations\, to a lack of manufacturing technologies designed for small-scale clinical production.  \nThis webinar explores how optimized ionizable LNP formulations improve the delivery of multi-epitope mRNA cancer vaccine candidates while supporting safety and immune-targeted expression. We will share findings from repeat intramuscular dosing studies demonstrating favorable tolerability and extended survival in tumor‑bearing mice.  \nYou will also learn how pairing advanced LNP design with small‑scale clinical manufacturing technologies enables a smoother transition from early development to clinical evaluation. By aligning formulation strategy with scalable process designs\, teams can ensure PCV candidates are potent and ready for clinical translation. \nJoin this webinar to learn:\n~   Why current PCV delivery strategies fall short—and how next-generation ionizable lipid formulations address safety and tissue-targeting limitations\n~   How optimized ionizable lipids enhance effective LNP-mediated delivery\, mRNA translation\, and antigen presentation for multi‑epitope mRNA cancer vaccines\n~   Key findings from repeated intramuscular dosing studies\, including maintained critical quality attributes (CQAs)\, no detectable toxicity\, and extended survival in tumor‑bearing mice\n~   Practical considerations for building PCV manufacturing workflows that transition seamlessly from concept to clinic using technologies purpose-built for small-scale clinical production \nSpeaker:\nMartin Rabel\nGlobal Sales Specialist\, BioPharma Services\, Cytiva\nMartin Rabel\, Ph.D.\, leads the commercial strategy for Cytiva’s BioPharma Services portfolio across EMEA and APAC. In this role\, he supports the advancement of nucleic acid–based therapies by enabling access to Cytiva’s proprietary lipid nanoparticle (LNP) platform and its integrated suite of nanoparticle development\, analytical\, and cGMP-compliant manufacturing services.\nMartin plays a key part in shaping and expanding this rapidly growing area of Cytiva’s offering. With a background as a trained Pharmacist and deep technical expertise in nanomedicine and RNA–LNP technologies\, he is committed to delivering exceptional customer guidance along with strong scientific and commercial excellence.
URL:https://thebiocalendar.com/event/unlocking-the-next-wave-of-cancer-vaccines-advancing-mrna-lnp-delivery-and-small-scale-manufacturing/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-21-26-Cytiva-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260421T110000
DTEND;TZID=America/Los_Angeles:20260421T120000
DTSTAMP:20260421T090002
CREATED:20260327T122913Z
LAST-MODIFIED:20260327T122913Z
UID:10096-1776769200-1776772800@thebiocalendar.com
SUMMARY:We Mapped What Sites Actually Do to Prepare Source Docs - The Results Are Eye-Opening
DESCRIPTION:In late 2025\, Tufts CSDD and CRIO conducted a survey among a global community of investigative sites to better understand how sites translate clinical trial protocols and related information into practical tools such as template source documents\, study plans\, calendars\, worksheets and shadow charts for the purposes of ensuring compliant\, efficient\, and high-quality data collection. In total\, 209 sites from a variety of settings responded. This session will review key takeaways from this research and discuss their implications.  \nThis source preparation process is not well understood and the lack of standardized terms describing the process are a source of confusion.  At the same time\, it is widely acknowledged that the process of source document preparation at investigative sites is inefficient and highly fragmented. This webinar will provide an overview to the comprehensive mapping of systems and workflows that investigative sites use to capture\, manage and transmit clinical research data; characterize pain points and challenges that drive delays; and identify opportunities to improve efficiency\, speed and quality. \nThe webinar will begin with a short presentation of the study results. Next\, a panel of investigative site representatives will discuss the findings and insights. \nKey learning objectives: \nReview the typical site workflow for preparing source documents and the critical and rate-limiting documents needed\n– Examine the roles and work effort required to prepare source documents and how this varies based on protocol complexity\n– Discuss the wide range of paper and electronic systems that sites use to capture relevant study information\n– Identify opportunities for sponsors\, sites and service providers to enhance the protocol-guided source preparation process and accelerate study activation times
URL:https://thebiocalendar.com/event/we-mapped-what-sites-actually-do-to-prepare-source-docs-the-results-are-eye-opening/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-21-26-CRIO-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260421T130000
DTEND;TZID=America/Los_Angeles:20260421T140000
DTSTAMP:20260421T090002
CREATED:20260318T144018Z
LAST-MODIFIED:20260318T144018Z
UID:10033-1776776400-1776780000@thebiocalendar.com
SUMMARY:Small Molecule Drug Product Capabilities Update
DESCRIPTION:Watch leading CDMOs share their current capabilities\, facility locations\, and timelines – to help you identify options for your development and manufacturing needs. \nWhat can you expect? – Short\, digital presentations to give you an inside look at the available capacity of industry suppliers. You will have the opportunity to ask questions of each CDMO to better understand if they can meet your needs – all from the convenience of your computer! \nPlease note that this event is for biopharma companies seeking to connect with CDMOs who have the capabilities that fit their needs.
URL:https://thebiocalendar.com/event/small-molecule-drug-product-capabilities-update/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/Biocal-11.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260422
DTEND;VALUE=DATE:20260424
DTSTAMP:20260421T090002
CREATED:20260116T133300Z
LAST-MODIFIED:20260116T133300Z
UID:9795-1776816000-1776988799@thebiocalendar.com
SUMMARY:AI x Next Generation Clinical Trials
DESCRIPTION:AI x Next Generation Clinical Trials is the premier event for exploring how artificial intelligence is revolutionizing clinical trial design\, execution\, and outcomes. This inaugural conference brings together industry leaders\, AI innovators\, and clinical trial experts to discuss the latest advancements in AI-driven patient recruitment\, trial optimization\, and data analysis. Gain actionable insights into leveraging AI to accelerate timelines\, reduce costs\, and improve trial success rates. With a focus on real-world applications\, emerging technologies\, and regulatory considerations\, this event is your opportunity to transform your approach to innovation and efficiency.
URL:https://thebiocalendar.com/event/ai-x-next-generation-clinical-trials/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260422T110000
DTEND;TZID=America/Los_Angeles:20260422T120000
DTSTAMP:20260421T090002
CREATED:20260318T144305Z
LAST-MODIFIED:20260318T144305Z
UID:10037-1776855600-1776859200@thebiocalendar.com
SUMMARY:Fill Finish Capabilities Update
DESCRIPTION:Explore leading CDMOs’ capabilities\, facility locations\, and timelines to identify the right partners for your development and manufacturing needs. Gain insights into critical fill-finish processes\, including sterile filling\, lyophilization\, and packaging\, while engaging directly with suppliers through interactive presentations. \nPlease note that this event is for biopharma companies seeking available capacity to connect with CDMOs who have that capacity available.
URL:https://thebiocalendar.com/event/fill-finish-capabilities-update/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/Biocal-12.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260422T110000
DTEND;TZID=America/Los_Angeles:20260422T120000
DTSTAMP:20260421T090002
CREATED:20260326T133852Z
LAST-MODIFIED:20260326T133852Z
UID:10074-1776855600-1776859200@thebiocalendar.com
SUMMARY:One Program\, Many CDMOs: Managing Multi-Partner Strategies
DESCRIPTION:Join Outsourced Pharma Live’s next virtual event to learn practical strategies for aligning external partners\, improving oversight\, and managing the real cost and risk of outsourcing across multiple locations.
URL:https://thebiocalendar.com/event/one-program-many-cdmos-managing-multi-partner-strategies/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/26_04-OPL-HTML-600x300-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260424
DTSTAMP:20260421T090002
CREATED:20260410T131837Z
LAST-MODIFIED:20260410T131837Z
UID:10189-1776902400-1776988799@thebiocalendar.com
SUMMARY:Biocom Converge Summit
DESCRIPTION:Biocom’s Converge Summit brings together the brightest minds in the life science\, medtech and technology sectors to explore transformative ideas\, build relationships and ignite partnerships that can change the world. Attendees will have the chance to engage in critical conversations with industry leaders\, explore the latest research and development\, and gain valuable insights into the emerging trends and opportunities that are driving growth and innovation.
URL:https://thebiocalendar.com/event/biocom-converge-summit/
LOCATION:South San Francisco\, CA\, CA\, 94080\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260423T010000
DTEND;TZID=America/Los_Angeles:20260423T140000
DTSTAMP:20260421T090002
CREATED:20260320T124345Z
LAST-MODIFIED:20260320T124345Z
UID:10049-1776906000-1776952800@thebiocalendar.com
SUMMARY:Advancing in-line PAT Solutions for Real-Time Batch Analysis
DESCRIPTION:This webinar explores how in-line PAT and real-time metabolic monitoring improve batch control\, reduce risk\, and increase yield. Learn how continuous glucose and lactate sensing provides accurate\, non-invasive data to optimize processes\, enhance consistency\, and support faster\, more informed decision-making.
URL:https://thebiocalendar.com/event/advancing-in-line-pat-solutions-for-real-time-batch-analysis/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-23-26-PHC-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260423T110000
DTEND;TZID=America/Los_Angeles:20260423T120000
DTSTAMP:20260421T090002
CREATED:20260320T124032Z
LAST-MODIFIED:20260320T124032Z
UID:10045-1776942000-1776945600@thebiocalendar.com
SUMMARY:Unlocking The Power Of Primary Care In Chronic Disease Research
DESCRIPTION:Chronic disease management largely takes place in primary care settings\, where patients rely on trusted physicians within their communities. A historically underrepresented and untapped area of clinical research\, engaging primary care physicians (PCPs) presents a powerful opportunity to access new\, more diverse patient pools that are critical to success in a competitive research environment. \nJoin our experts as they explore the opportunities presented by utilizing PCPs in chronic disease research – including accelerating patient identification\, accessing underrepresented patient populations\, retaining patients in long-term trials and better understanding how potential treatments work in a real-world setting. \nKey learning objectives:\n– Understanding the critical role PCPs play in chronic disease management and the value they bring to clinical research\n– Identifying best practices for training and supporting PCPs as investigators and referral partners\n– Navigating global regulations and guidance related to engaging PCPs across regions
URL:https://thebiocalendar.com/event/unlocking-the-power-of-primary-care-in-chronic-disease-research/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/Untitled-design-60.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260423T110000
DTEND;TZID=America/Los_Angeles:20260423T120000
DTSTAMP:20260421T090002
CREATED:20260331T195345Z
LAST-MODIFIED:20260331T195345Z
UID:10121-1776942000-1776945600@thebiocalendar.com
SUMMARY:Just Breathe: Increasing Efficacy And Expanding Targets With Inhalation Delivery
DESCRIPTION:This Drug Delivery panel discussion will illuminate ways in which innovations in inhalation\, via both oral and nasal routes to respiratory pathways and the lungs\, are increasing patient convenience and therapeutic efficacy while expanding the range of targeted indications. Host Tom von Gunden will engage expert panelists Nani Kadrichu\, David Morton\, Stephen Stein\, and Geraldine Venthoye in a focused look at advances in formulation science and device technology for inhalers\, nebulizers\, and combination products. \nThe panel will illuminate formulation and device design considerations for various scenarios\, including:\no    Overcoming delivery challenges while addressing common or unmet therapeutic needs\no    Leveraging the lungs as a pathway to therapeutic indications beyond respiratory\no    Fostering non-clinical applications\, including for at home\, self-administration\no    Maintaining affordability while advancing sustainable\, “green” initiatives\no    Transitioning formerly IV- or injection-only administered therapies (e.g.\, large molecule biologics) to inhalation options)
URL:https://thebiocalendar.com/event/just-breathe-increasing-efficacy-and-expanding-targets-with-inhalation-delivery/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/Biocal-13.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260423T130000
DTEND;TZID=America/Los_Angeles:20260423T140000
DTSTAMP:20260421T090002
CREATED:20260331T151627Z
LAST-MODIFIED:20260331T151627Z
UID:10117-1776949200-1776952800@thebiocalendar.com
SUMMARY:Advancing in-line PAT Solutions for Real-Time Batch Analysis
DESCRIPTION:This webinar will discuss how continuous metabolic insight improves feeding strategies\, strengthens process understanding\, and supports early detection of culture stress—ultimately reducing batch risk and improving yield. Participants will gain a clear understanding of how advanced electrochemical sensing can support Quality by Design (QbD) principles\, enhance process robustness\, and drive more predictive\, efficient batch operations.
URL:https://thebiocalendar.com/event/advancing-in-line-pat-solutions-for-real-time-batch-analysis-2/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-23-26-PHC-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260424T110000
DTEND;TZID=America/Los_Angeles:20260424T120000
DTSTAMP:20260421T090002
CREATED:20260331T200440Z
LAST-MODIFIED:20260331T200440Z
UID:10125-1777028400-1777032000@thebiocalendar.com
SUMMARY:Biologics Tech Transfer & Validation at Scale: A Better Path to GMP
DESCRIPTION:In this session\, we’ll break down where tech transfer and validation most often go wrong\, and how experienced teams proactively manage risk across scale-up\, site transfer\, and PPQ. \nYou’ll learn:\n– Where scale-up and tech transfer introduce the greatest risk—and how to spot issues early\n– How to translate process knowledge into consistent performance across sites and scales\n– What’s required for PPQ and continued verification to support efficient\, compliant progression
URL:https://thebiocalendar.com/event/biologics-tech-transfer-validation-at-scale-a-better-path-to-gmp/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-24-26-Avid-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260427
DTEND;VALUE=DATE:20260501
DTSTAMP:20260421T090002
CREATED:20260327T142423Z
LAST-MODIFIED:20260327T142423Z
UID:10109-1777248000-1777593599@thebiocalendar.com
SUMMARY:BPI Europe
DESCRIPTION:Join us as we return to Vienna\, a globally recognized meeting destination and one of Europe’s premier life science hubs. The city is home to the renowned Vienna BioCenter\, a nexus of academic research and over 50 innovative biotech companies\, alongside industry leaders like Boehringer Ingelheim\, Takeda and Novartis. This powerful combination of scientific excellence\, seamless accessibility\, and rich cultural heritage provides the ideal backdrop to connect with global pioneers and forge the collaborations that will drive the future of bioprocessing.
URL:https://thebiocalendar.com/event/bpi-europe/
LOCATION:Vienna\, Vienna\, 1300\, Austria
CATEGORIES:Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260427T110000
DTEND;TZID=America/Los_Angeles:20260427T120000
DTSTAMP:20260421T090002
CREATED:20260407T185655Z
LAST-MODIFIED:20260407T185655Z
UID:10146-1777287600-1777291200@thebiocalendar.com
SUMMARY:From DNA to IND in as little as 6 months
DESCRIPTION:Explore how innovative CMC strategies are transforming early antibody development. Learn how an integrated approach can accelerate the path from DNA to IND to as little as six months\, without compromising quality or regulatory alignment. \nBacked by over 30 years of biologics expertise\, this session will highlight cutting-edge technologies\, platform-driven workflows\, and parallel development strategies that reduce risk and enable rapid clinical readiness. Attendees will also gain practical insights into avoiding common bottlenecks and building scalable\, efficient development plans in partnership with a CDMO.
URL:https://thebiocalendar.com/event/from-dna-to-ind-in-as-little-as-6-months/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/04-27-26-Lonza-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260427T110000
DTEND;TZID=America/Los_Angeles:20260427T120000
DTSTAMP:20260421T090002
CREATED:20260408T122806Z
LAST-MODIFIED:20260408T122806Z
UID:10154-1777287600-1777291200@thebiocalendar.com
SUMMARY:From First Click to Randomization: Improving Patient Qualification in Psychiatry Trials
DESCRIPTION:Moving patients successfully from initial interest to randomization is one of the most critical and challenging steps in psychiatry clinical trials. Many studies experience significant drop-off during the qualification and screening stages due to strict eligibility criteria\, incomplete patient information\, and inefficient referral processes. \nThis webinar focuses on strategies to improve patient qualification and increase the number of patients progressing to randomization. Learn how sponsors can optimize recruitment workflows\, enhance patient screening processes\, and ensure that sites receive better-qualified patients. \nKey Learning Objectives:\n– Improve patient qualification processes to increase the number of eligible patients reaching study sites\n– Reduce patient drop-off between initial interest\, screening\, and randomization\n– Implement recruitment strategies that support faster enrollment and improved site performance
URL:https://thebiocalendar.com/event/from-first-click-to-randomization-improving-patient-qualification-in-psychiatry-trials/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/04-27-26-Autocruitment-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260430
DTSTAMP:20260421T090002
CREATED:20251209T120633Z
LAST-MODIFIED:20251209T120633Z
UID:9639-1777334400-1777507199@thebiocalendar.com
SUMMARY:Cell & Gene Therapy Summit
DESCRIPTION:A Decade of Expertise\, Now in China: Cell & Gene Therapy Summit 2026 \n\n\n\nWith over a decade of experience hosting premier cell and gene therapy events in the US and Europe\, attracting 1\,500+ attendees annually\, Cell & Gene Therapy International is bringing its expertise to China. The 2026 summit in Shanghai is designed to foster collaboration among top researchers\, biopharmaceutical leaders\, and industry pioneers\, with a focus on cutting-edge R&D\, manufacturing excellence\, and strategic partnerships. Attendees will gain unparalleled insights into breakthrough methodologies across cell therapies\, gene editing platforms\, viral vector technologies\, and the discovery-to-clinic continuum—empowering them to drive innovation and growth in the China market.
URL:https://thebiocalendar.com/event/cell-gene-therapy-summit/
LOCATION:Shanghai\, Shanghai\, China
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260430
DTSTAMP:20260421T090002
CREATED:20251210T120316Z
LAST-MODIFIED:20251210T120316Z
UID:9640-1777334400-1777507199@thebiocalendar.com
SUMMARY:ChinaBio Partnering Forum
DESCRIPTION:The ChinaBio Partnering Forum is China’s premier life science event\, connecting global biopharma with China’s market for strategic partnerships\, investment\, and innovation\, featuring partneringONE technology\, company pitches (like Startup Spotlight)\, expert panels\, and networking to accelerate cross-border deals.
URL:https://thebiocalendar.com/event/chinabio-partnering-forum-3/
LOCATION:Shanghai\, Shanghai\, China
CATEGORIES:Forum,Partnering
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260428
DTEND;VALUE=DATE:20260501
DTSTAMP:20260421T090002
CREATED:20260130T130200Z
LAST-MODIFIED:20260202T184211Z
UID:9838-1777334400-1777593599@thebiocalendar.com
SUMMARY:3rd Biophysics for Drug Discovery Summit 
DESCRIPTION:The 3rd Biophysics for Drug Discovery Summit offers a rare\, highly technical\, industry-focused forum dedicated solely to biophysics. Unlike broader drug discovery meetings\, this summit provides a comprehensive view of techniques\, emerging technologies\, and practical applications. Through case studies\, panel discussions\, and interactive dialogue\, attendees will explore how next-generation biophysics drives predictive pipelines and accelerates discovery.  \nTo find out more\, please view the full 2026 event program here: https://ter.li/efenue
URL:https://thebiocalendar.com/event/3rd-biophysics-for-drug-discovery-summit/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260428T080000
DTEND;TZID=America/Los_Angeles:20260428T130000
DTSTAMP:20260421T090002
CREATED:20260327T140548Z
LAST-MODIFIED:20260327T140548Z
UID:10106-1777363200-1777381200@thebiocalendar.com
SUMMARY:Southern California Life Sciences & Biotech Summit
DESCRIPTION:What You’ll Learn:  \n\nMapping the Next Frontier of Growth: How Southern California’s biotech\, pharma\, therapeutics and medtech industries are evolving\, and which markets are maturing fastest.\nCommercial Real Estate Outlook: How landlords\, developers and owners are adapting to laboratory and biomanufacturing requirements in a rapidly advancing industry.\nFunding & Investment Conditions: Who is investing\, what types of science attract capital today\, and how financing is shifting in 2026.\nCommercialization & Scaling: How startups are moving from discovery to proof-of-concept\, early manufacturing and commercial deployment—plus how real estate plays into that journey.\nTechnology & Infrastructure Innovation: How AI\, data science\, robotics and automation are influencing design requirements and operational decision-making.\nInstitutional Partnerships: How universities\, research institutions and government are shaping growth through capital\, workforce pipelines and innovation accelerators.\n\n  \nHow You’ll Do More Business From Attending This CRE Event: Southern California life sciences market is driven by an expanding biotech startup ecosystem\, a surge in late-stage developments\, a diversified talent pool\, and accelerating commercialization of research coming from world-class institutions. San Diego\, Orange County\, and Greater Los Angeles are providing new territory for investors\, developers\, property owners\, and operators to capture market share. Join leaders across biotech\, R&D\, real estate\, investment\, and government as we explore the forces sha
URL:https://thebiocalendar.com/event/southern-california-life-sciences-biotech-summit/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260428T110000
DTEND;TZID=America/Los_Angeles:20260428T120000
DTSTAMP:20260421T090002
CREATED:20260326T185458Z
LAST-MODIFIED:20260326T185458Z
UID:10088-1777374000-1777377600@thebiocalendar.com
SUMMARY:Closing The Adoption Gap For Advanced Single-Use Materials
DESCRIPTION:Despite nearly two decades of industry surveys demonstrating a steady demand for new and improved single-use technologies\, next-generation films\, polymers\, and components struggle to achieve widespread adoption. \nJoin Bioprocess Online’s Tyler Menichiello for an interactive panel discussion examining how regulatory lag\, evolving biocompatibility standards\, and the complexity of converting legacy systems slow the uptake of innovative single-use materials in biomanufacturing. This conversation will feature BioPlan Associates’ director of research\, Katrina Cordovado\, and consultant Paul Priebe\, a single-use bioprocessing technology expert. They will discuss the validation challenges new technologies and materials face\, highlighting the standards bodies and industry organizations working to improve harmonization and what these efforts mean for manufacturers evaluating these materials.
URL:https://thebiocalendar.com/event/closing-the-adoption-gap-for-advanced-single-use-materials/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/26_04-BPOL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T110000
DTEND;TZID=America/Los_Angeles:20260429T120000
DTSTAMP:20260421T090002
CREATED:20260327T123222Z
LAST-MODIFIED:20260327T123222Z
UID:10100-1777460400-1777464000@thebiocalendar.com
SUMMARY:Driving Smarter Chemistry in Drug Discovery: Using Full DEL Data to Improve Early Compound Decisions
DESCRIPTION:Modern screening approaches generate rich datasets that capture how large collections of compounds interact with biological targets. However\, discovery teams often rely on only a small portion of that information when selecting compounds for synthesis\, potentially missing important signals across the broader dataset. \nIn this webinar\, we explore how evaluating the full screening landscape can reveal structure–function insight across related compounds. This approach helps guide more informed chemistry decisions. By looking beyond individual hits\, scientists can better understand which chemical series merit further investment and which should be deprioritized earlier in the program. \nKey Learning Objectives:\n– How evaluating the full DEL screening dataset can reveal meaningful patterns across related compounds\, not just individual enriched binders\n– Why examining structure–function trends across chemical series can improve confidence in early synthesis decisions\n– How a more complete view of DEL data can help discovery teams prioritize the right series and reduce downstream risk
URL:https://thebiocalendar.com/event/driving-smarter-chemistry-in-drug-discovery-using-full-del-data-to-improve-early-compound-decisions/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-29-26-XChem-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T110000
DTEND;TZID=America/Los_Angeles:20260429T120000
DTSTAMP:20260421T090002
CREATED:20260407T114850Z
LAST-MODIFIED:20260407T114850Z
UID:10134-1777460400-1777464000@thebiocalendar.com
SUMMARY:Execution Without Direction: The Hidden Risk in Outsourced Clinical Trials
DESCRIPTION:As clinical trials become increasingly outsourced\, a critical gap has emerged between sponsor expectations and CRO execution. Many smaller biotech companies rely heavily on outsourcing vendors to drive their programs\, often without the internal clinical operations infrastructure needed to provide direction\, oversight\, and strategic alignment. \nAt the same time\, vendor teams—particularly CRAs—are frequently stretched thin and charged with executing small tasks without understanding the bigger picture. The result is a growing disconnect: between sponsors and CROs\, CRAs and sites\, and protocols and real-world operations. These gaps can lead to inefficiencies\, risks\, and strained site relationships that ultimately impact study success. \nIn this live webinar\, industry experts will explore the root causes of this disconnect and examine whether clinical oversight monitors are a necessary evolution\, or an added layer of complexity. Through real-world insights and practical examples\, we’ll discuss how organizations can better align stakeholders\, improve trial execution\, and close the widening operational gap. \nIn this webinar\, you will:\n– Understand the structural gaps that commonly exist between sponsors\, CROs\, and clinical sites\n– Learn why traditional CRO models may fall short in providing strategic clinical oversight\n– Identify the risks and inefficiencies that arise from fragmented clinical operations\n– Explore the role of oversight functions in improving alignment\, quality\, and site relationships\n– Gain practical strategies for strengthening collaboration and ensuring more cohesive trial execution
URL:https://thebiocalendar.com/event/execution-without-direction-the-hidden-risk-in-outsourced-clinical-trials/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/04-29-26-ISG-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260429T130000
DTEND;TZID=America/Los_Angeles:20260429T140000
DTSTAMP:20260421T090002
CREATED:20260323T180943Z
LAST-MODIFIED:20260323T180943Z
UID:10055-1777467600-1777471200@thebiocalendar.com
SUMMARY:How Connected Manufacturing Operations Unlock AI's Potential to Optimize Production
DESCRIPTION:Research findings from 150 manufacturing leaders uncovered a “connectivity crisis” preventing production optimization. This webinar addresses the imperative to break down the silos today that are creating the delays\, rework\, and compliance issues that 90%-plus manufacturers struggle with. Start at the bottom and build the connected data foundation that makes AI actually work.
URL:https://thebiocalendar.com/event/how-connected-manufacturing-operations-unlock-ais-potential-to-optimize-production/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-29-26-MasterControl-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T110000
DTEND;TZID=America/Los_Angeles:20260430T120000
DTSTAMP:20260421T090002
CREATED:20260323T183444Z
LAST-MODIFIED:20260323T183444Z
UID:10059-1777546800-1777550400@thebiocalendar.com
SUMMARY:Alert to Action: How Connected Digital Execution Turns Pharma Data into Decisions
DESCRIPTION:In this session\, explore how digitally connected execution ecosystems move manufacturers from reactive response to proactive control\, enabling faster decisions\, fewer errors\, and inspection-ready operations by design.
URL:https://thebiocalendar.com/event/alert-to-action-how-connected-digital-execution-turns-pharma-data-into-decisions/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-30-26-Honeywell-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T110000
DTEND;TZID=America/Los_Angeles:20260430T120000
DTSTAMP:20260421T090002
CREATED:20260330T113959Z
LAST-MODIFIED:20260330T113959Z
UID:10111-1777546800-1777550400@thebiocalendar.com
SUMMARY:Radiopharmaceuticals: New Opportunities And Overcoming Operational Hurdles
DESCRIPTION:Radiopharmaceuticals and radioligand therapies were involved in multibillion dollar M&A transactions over the last several years. Panelists on this Life Science Leader virtual event will discuss emerging technologies and radioisotopes\, what new market opportunities exist\, and what manufacturing and delivery challenges remain for radiopharmaceutical developers.   \nRegistered attendees will have the opportunity to pose their own questions to panel participants\, so come prepared to connect\, collaborate\, and contribute on April 30\, 2026\, 11 AM ET.
URL:https://thebiocalendar.com/event/radiopharmaceuticals-new-opportunities-and-overcoming-operational-hurdles/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/26_04-LSL-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260430T110000
DTEND;TZID=America/Los_Angeles:20260430T120000
DTSTAMP:20260421T090002
CREATED:20260407T190132Z
LAST-MODIFIED:20260407T190132Z
UID:10150-1777546800-1777550400@thebiocalendar.com
SUMMARY:Engineering Precision in Genetic Medicines
DESCRIPTION:Discover how precision genome editing is advancing the next generation of genetic medicines. Learn strategies to achieve highly specific\, potent DNA edits while minimizing off-target effects and meeting rigorous safety standards for clinical translation. \nWhat you’ll learn:\n– How to precisely correct disease mutations without creating unwanted edits\n– Engineering and optimizing DNA recognition to enhance specificity across genome editing modalities\n– AI-driven iterative workflows for designing bespoke gene editors with both high potency and specificity\n– Practical strategies to minimize bystander and off-target editing for safer therapeutics\n– Real-world insights from using adenine base editors as a case study
URL:https://thebiocalendar.com/event/engineering-precision-in-genetic-medicines/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/04-30-26-Elevate-eBlast-700x200-1.png
END:VEVENT
END:VCALENDAR